Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Apr 23;11:8863. doi: 10.1038/s41598-021-88346-w

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021, corrected publication 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Effect of ulipristal and/or metformin on the expression of proteins involved in glucose metabolism in rats’ uteri. (A–D) photomicrographs of uteri shows expression of 3-PHGDH. (A) Uterine wall in the control group. (B) Uterine wall in ulipristal treated group. (C) Uterine wall in metformin treated group. (D) Uterine wall in the ulipristal and metformin treated group. × 400 magnification (scale bar = 20 μm). (E) Expression quantification of the optical density reactivity of positive cells of 3-PHGDH by the ImageJ analysis system. (F–I). Photomicrographs of uteri shows expression of G6PD. (F) Uterine wall in the control group. (G) Uterine wall in ulipristal treated group. (H) Uterine wall in metformin treated group. (I) Uterine wall in the ulipristal and metformin treated group. × 400 magnification (scale bar = 20 μm). (J) Expression quantification of the optical density reactivity of positive cells of G6PD by the ImageJ analysis system. (K–N) Photomicrographs of uteri shows expression of TKT. (K) Uterine wall in the control group. (L) Uterine wall in ulipristal treated group. (M) Uterine wall in metformin treated group. (N) Uterine wall in ulipristal and metformin treated group. × 400 magnification (scale bar = 20 μm). (O) Expression quantification of the optical density reactivity of positive cells of TKT by the ImageJ analysis system. Data in figures (E & J & O) is represented by mean ± SD (n = 7). a or b, Statistically significant from the control or ulipristal & metformin treated group respectively at P < 0.05 using one-way ANOVA followed by Tukey as a post hoc test. UPA ulipristal, MET metformin, UPA + MET co-treatment with ulipristal and metformin.